SCHEMBL24495331

SCHEMBL24495331

COc1ccc([C@@H](C)N(CC=C(c2ccccc2)c2ccccc2)C(C)=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.47
MTNR1A P48039 2/20 0.44
MTNR1B P49286 2/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MAPT P10636 1/20 0.43
PAX8 Q06710 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ALDH1A1 P00352 2/20 0.43
HSD17B10 Q99714 1/20 0.43
TRPM8 Q7Z2W7 1/20 0.43
TSHR P16473 1/20 0.43
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24495181 0.87 TSHR (0.46) MEN1KMT2AL3MBTL1MTNR1AMTNR1B
SCHEMBL24495113 0.87 L3MBTL1 (0.44) MEN1KMT2AL3MBTL1MTNR1AMTNR1B
SCHEMBL24495071 0.87 L3MBTL1 (0.44) MEN1KMT2AL3MBTL1MTNR1AMTNR1B
SCHEMBL24495135 0.85 L3MBTL1 (0.43) MEN1KMT2AL3MBTL1MTNR1AMTNR1B
SCHEMBL24495121 0.85 NPY5R (0.49) MEN1KMT2ANPC1RAB9AMAPT
SCHEMBL24495280 0.85 L3MBTL1 (0.45) MEN1KMT2AL3MBTL1MTNR1AMTNR1B
SCHEMBL24495295 0.84 L3MBTL1 (0.42) MEN1KMT2AL3MBTL1MTNR1AMTNR1B
SCHEMBL17291618 0.83 L3MBTL1 (0.46) MEN1KMT2AL3MBTL1MTNR1AMTNR1B
SCHEMBL15571219 0.83 L3MBTL1 (0.46) MEN1KMT2AL3MBTL1MTNR1AMTNR1B
SCHEMBL24495053 0.82 L3MBTL1 (0.46) MEN1KMT2AL3MBTL1MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043602-B2 Fendiline derivatives THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2024-07-23 US disclosed
US-12043602-B2 Fendiline derivatives THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2024-07-23 US disclosed
US-12043602-B2 Fendiline derivatives THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2024-07-23 US disclosed
US-20220177440-A1 Fendiline Derivatives THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2022-06-09 US disclosed
US-20220177440-A1 Fendiline Derivatives THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2022-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12043602-B2 Fendiline derivatives CYP11B2, CYP3A7, CYP4F2 MEN1 3333/4885KMT2A 3225/4885L3MBTL1 4482/4885
US-20220177440-A1 Fendiline Derivatives CYP11B2, CYP3A7, CYP4F2 MEN1 3333/4885KMT2A 3225/4885L3MBTL1 4482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.